1. Mandy FF (2004): Twenty-five years of clinical flow cytometry: AIDS accelerated global instrument distribution. Cytometry 58: 55-56.
2.
Giorgi JV, Lyles RH, Matud JL, et al. (2002): Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infection. J Acquir Immune Defic Syndr 29: 346-355.
3.
van Dongen JJM, van der Burg M, Kalina T, et al. (2019): EuroFlow-based flowcytometric diagnostic screening and classification of primary immunodeficiencies of the lymphoid system. Front Immunol 10: 1271.
4.
Boldt A, Borte S, Fricke S, et al. (2014): Eight-color immunophenotyping of T-, B-, and NK-cell subpopulations for characterization of chronic immunodeficiencies. Cytometry B Clin Cytom 86: 191-206.
5.
Matarraz S, Almeida J, Flores-Montero J, et al. (2017): Introduction to the diagnosis and classification of monocytic-lineage leukemias by flow cytometry. Cytometry B Clin Cytom 92: 218-227.
6.
Theunissen P, Mejstrikova E, Sedek L, et al. (2017): Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia. Blood 129: 347-357.
7.
van Eeden SF, Klut ME, Walker BA, et al. (1999): The use of flow cytometry to measure neutrophil function. J Immunol Methods 232: 23-43.
8.
Nielsen CM, White MJ, Goodier MR, et al. (2013): Functional significance of CD57 expression on human NK cells and relevance to disease. Front Immunol 4: 422.
9.
Bridts CH, et al. (2014): Flow cytometric allergy diagnosis: basophil activation techniques. In: Basophils and mast cells: Methods and protocols. Gibbs BF, Falcone FH (Eds.). Springer New York, New York, NY; 147-159.
10.
Torres MJ, Padial A, Mayorga C, et al. (2004): The diagnostic interpretation of basophil activation test in immediate allergic reactions to betalactams. Clin Exp Allergy 34: 1768-1775.
11.
Azargoon A, Mirrasouli Y, Barough MS, et al. (2019): The state of peripheral blood natural killer cells and cytotoxicity in women with recurrent pregnancy loss and unexplained infertility. Int J Fertil Steril 13: 12-17.
12.
Vaquero E, Lazzarin N, Caserta D, et al. (2006): Diagnostic evaluation of women experiencing repeated in vitro fertilization failure. Eur J Obstet Gynecol Reprod Biol 125: 79-84.
13.
Jerzak M, Kniotek M, Mrozek J, et al. (2008): Sildenafil citrate decreased natural killer cell activity and enhanced chance of successful pregnancy in women with a history of recurrent miscarriage. Fertil Steril 90: 1848-1853.
14.
Kwak JY, Kwak FM, Ainbinder SW, et al. (1996): Elevated peripheral blood natural killer cells are effectively downregulated by immunoglobulin G infusion in women with recurrent spontaneous abortions. Am J Reprod Immunol 35: 363-369.
15.
Ahmadi M, Abdolmohammadi-Vahid S, Ghaebi M, et al. (2017): Effect of Intravenous immunoglobulin on Th1 and Th2 lymphocytes and improvement of pregnancy outcome in recurrent pregnancy loss (RPL). Biomed Pharmacother 92: 1095-1102.
16.
McCusker C, Warrington R (2011): Primary immunodeficiency. Allergy Asthma Clin Immunol 7 Suppl 1 (Suppl 1): S11.
17.
Tangye SG, Al-Herz W, Bousfiha A, et al. (2020): Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol 40: 24-64.
18.
Picard C, Gaspar HB, Al-Herz W, et al. (2018): International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee Report on Inborn Errors of Immunity. J Clin Immunol 38: 96-128.
19.
Bousfiha AA, Jeddane L, Ailal F, et al. (2013): Primary immunodeficiency diseases worldwide: more common than generally thought. J Clin Immunol 33: 1-7.
20.
Schulman R (1995): Primary immune deficiency diseases in America: The first national survey of patients and specialists. Available from: https: //primaryimmune.org/publication/surveys/primary-immune-deficiency-diseases-america-first- national-survey-patients-and.
21.
Rosenberg E, Dent PB, Denburg JA (2016): Primary immune deficiencies in the adult: a previously underrecognized common condition. J Allergy Clin Immunol Pract 4: 1101-1107.
22.
Chapel H, Lucas M, Lee M, et al. (2008): Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood 112: 277-286.
23.
Resnick ES, Moshier EL, Godbold JH, et al. (2012): Morbidity and mortality in common variable immune deficiency over 4 decades. Blood 119: 1650-1657.
24.
Cunningham-Rundles C, Bodian C (1999): Common variable immunodeficiency: Clinical and immunological features of 248 patients. Clin Immunol 92: 34-48.
25.
Ziętkiewicz M, Więsik-Szewczyk E, Matyja-Bednarczyk A, et al. (2020): Shorter diagnostic delay in polish adult patients with common variable immunodeficiency and symptom onset after 1999. Front Immunol 11: 982.
26.
Ghafoor A, Joseph SM (2020): Making a diagnosis of common variable immunodeficiency: A review. Cureus 12: e6711.
27.
Locke BA, Dasu T, Verbsky JW (2014): Laboratory diagnosis of primary immunodeficiencies. Clin Rev Allergy Immunol 46: 154-168.
28.
Ameratunga R, Woon ST, Gillis D, et al. (2013): New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulin. Clin Exp Immunol 174: 203-211.
29.
Patuzzo G, Barbieri A, Tinazzi E, et al. (2016): Autoimmunity and infection in common variable immunodeficiency (CVID). Autoimmun Rev 15: 877-882.
30.
Abinun M, Albert M, Beaussant S, et al. (2011): ESID Registry – Working Definitions for Clinical Diagnosis of PID. 2020 November 2019 (cited 2020 Jan 11). Available from: https://esid.org/Working-Parties/Registry-Working-Party/Diagnosis-criteria.
31.
Warnatz K, Denz A, Dräger R, et al. (2002): Severe deficiency of switched memory B cells (CD27(+)IgM(–)IgD(–)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 99: 1544-1551.
32.
Wehr C, Kivioja T, Schmitt C, et al. (2008): The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 111: 77-85.
33.
de Vries E; European Society for Immunodeficiencies (2012): Patient-centred screening for primary immunodeficiency, a multi-stage diagnostic protocol designed for non-immunologists: 2011 update. Clin Exp Immunol 167: 108-119.
34.
Piątosa B, Wolska-Kuśnierz B, Pac M, et al. (2010): B cell subsets in healthy children: Reference values for evaluation of B cell maturation process in peripheral blood. Cytometry B Clin Cytom 78B: 372-381.
35.
Kverneland AH, Streitz M, Geissler E, et al. (2016): Age and gender leucocytes variances and references values generated using the standardized ONE-Study protocol. Cytometry A 89: 543-564.
36.
Apoil PA, Puissant-Lubrano B, Congy-Jolivet N, et al. (2017): Influence of age, sex and HCMV-serostatus on blood lymphocyte subpopulations in healthy adults. Cell Immunol 314: 42-53.
37.
Shahal-Zimra Y, Rotem Z, Chezar J, et al. (2016): Lymphocyte subset reference ranges in healthy Israeli adults. Isr Med Assoc J 18: 739-743.
38.
Al-Thani A, Hamdi WS, Al-Marwani A, et al. (2015): Reference ranges of lymphocyte subsets in healthy Qatari adults. Biomark Med 9: 443-452.
39.
Valiathan R, Deeb K, Diamante M, et al. (2014): Reference ranges of lymphocyte subsets in healthy adults and adolescents with special mention of T cell maturation subsets in adults of South Florida. Immunobiology 219: 487-496.
40.
Kokuina E, Breff-Fonseca MC, Villegas-Valverde CA, et al. (2019): Normal values of T, B and NK lymphocyte subpopulations in peripheral blood of healthy Cuban adults. MEDICC Rev 21: 16-21.
41.
Uppal SS, Verma S, Dhot PS (2003): Normal values of CD4 and CD8 lymphocyte subsets in healthy Indian adults and the effects of sex, age, ethnicity, and smoking. Cytometry B Clin Cytom 52: 32-36.
42.
Gize A, Mathewos B, Moges B, et al. (2014): Establishment of normal reference intervals for CD3(+), CD4(+), CD8(+), and CD4(+) to CD8(+) ratio of T lymphocytes in HIV negative adults from University of Gondar Hospital, North West Ethiopia. AIDS Res Treat 2014: 267450.
43.
Kamallou A, Haji Abdolbaghi M, Mohraz M, et al. (2014): Reference values of lymphocyte sub-populations in healthy human immunodeficiency virus-negative Iranian adults. Iran J Immunol 11: 221-232.
44.
Al-Mawali A, Pinto AD, Busaidi RA, et al. (2013): Lymphocyte subsets: Reference ranges in an age- and gender-balanced population of Omani healthy adults. Cytometry A 83: 739-744.
45.
Villegas-Valverde CA, Kokuina E, Breff-Fonseca MC (2020): Determination of reference values for double-negative T lymphocytes in Cuban adults. MEDICC Rev 22: 48-50.
46.
Caraux A, Klein B, Paiva B, et al. (2010): Circulating human B and plasma cells. Age-associated changes in counts and detailed characterization of circulating normal CD138- and CD138+ plasma cells. Haematologica 95: 1016-1020.
47.
Laux I, Khoshnan A, Tindell C, et al. (2000): Response differences between human CD4(+) and CD8(+) T-cells during CD28 costimulation: implications for immune cell-based therapies and studies related to the expansion of double-positive T-cells during aging. Clin Immunol 96: 187-197.
48.
Overgaard NH, Jung JW, Steptoe RJ, et al. (2015): CD4+/CD8+ double-positive T cells: more than just a developmental stage? J Leukoc Biol 97: 31-38.
49.
Frasca D, Diaz A, Romero M, et al. (2011): Age effects on B cells and humoral immunity in humans. Ageing Res Rev 10: 330-335.
50.
Fish EN (2008): The X-files in immunity: sex-based differences predispose immune responses. Nat Rev Immunol 8: 737-744.
51.
Giefing-Kröll C, Berger P, Lepperdinger G, et al. (2015): How sex and age affect immune responses, susceptibility to infections, and response to vaccination. Ageing Cell 14: 309-321.
52.
Gubbels Bupp MR, Potluri T, Fink AL, et al. (2018): The confluence of sex hormones and aging on immunity. Front Immunol 9: 1269.
53.
Newell KA, Asare A, Kirk AD, et al. (2010): Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest 120: 1836-1847.
